GWO, CA39138C1068

Great-West Lifeco stock trades at EUR 56.71 with CAD 79.4 billion value

Published on 10/15/2026 at 10:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue hit CAD 12.72 billion in the second quarter. Great-West Lifeco stock costs EUR 56.71 on October 15, 2026, with CAD 79.4 billion value.

Quarterly performance and valuation

  • Revenue reached CAD 12.72 billion in the second quarter of 2026.
  • Adjusted earnings per share rose to CAD 1.16 from CAD 0.96 in the second quarter.
  • Great-West Lifeco stock traded at EUR 56.71 at 10:33 a.m. CEST at Lang & Schwarz on October 15, 2026.
GWO, CA39138C1068, Illustration mit AI erstellt.
GWO, CA39138C1068, Illustration mit AI erstellt.

Great-West Lifeco stock (ISIN CA39138C1068) trades at EUR 56.71 at Lang & Schwarz on October 15, 2026, while its market capitalization is CAD 79.4 billion. The latest quarterly figures show higher revenue and earnings, but analyst views remain measured.

Quarterly revenue sets the baseline

For the second quarter of 2026, Great-West Lifeco reported revenue of CAD 12.72 billion and net profit of CAD 1.09 billion, compared with CAD 10.39 billion and CAD 927 million in the same quarter of 2025. Markets Insider reported the comparison on October 8, 2026.

The structured financial data for the second quarter of 2026 shows diluted earnings per share of CAD 1.16. That was up from CAD 0.96 in the second quarter of 2025, while net income rose to CAD 1.04 billion. Simply Wall St published the figures on October 6, 2026.

Three dates frame the stock

On July 29, 2026, the second-quarter release showed CAD 1.16 in earnings per share against CAD 0.96 a year earlier. On September 3, 2026, Empower completed the Milliman retirement administration acquisition, adding about 800 employees and extending coverage to more than 22 million lives, according to Simply Wall St. On October 8, 2026, Markets Insider reported that Barclays maintained a Hold rating.

What does the valuation imply?

Barclays kept its Hold view on October 8, 2026, while the consensus target cited by Markets Insider stood at CAD 104.91. Evercore ISI had initiated coverage on September 29, 2026, with a Hold rating and a CAD 100.00 target. The contrast is important: operating figures improved, yet the analyst stance still leaves valuation and execution as central questions.

Next reporting date

The next scheduled earnings date is November 4, 2026, according to Investing.com. Great-West Lifeco operates through Canada Life, Empower and Irish Life across Canada, the United States and Europe, with more than 40 million customer relationships and 33,430 employees as of December 31, 2025, according to Great-West Lifeco.

Stock valuation meets operating growth

The stock combines a second-quarter revenue increase with a market value of CAD 79.4 billion. For investors, the November reporting date will provide the next test of whether Empower and the broader retirement business can sustain the earnings improvement.

Great-West Lifeco was trading at EUR 56.71 at Lang & Schwarz on October 15, 2026, at 10:33 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Great-West Lifeco stock.

Great-West Lifeco stock facts

  • Company: Great-West Lifeco Inc.
  • ISIN: CA39138C1068
  • Ticker: GWO
  • Primary exchange: Toronto Stock Exchange
  • Price Lang & Schwarz (as of October 15, 2026, 10:33 a.m. CEST): EUR 56.71
  • Market capitalization: CAD 79.4 billion (as of October 15, 2026)
  • Sector / Industry: Financials / Insurance
  • Next earnings date: November 4, 2026

Market context: Market report S&P/TSX Composite.

More news and analyses on Great-West Lifeco stock

Disclaimer...
en | CA39138C1068 | GWO | boerse | 70327413 | bgmi